Sony's Animated Venom Movie: Can Horror Directors Make the Spider-Verse Formula Work Twice?

Sony Pictures Animation is making an animated Venom movie. The symbiote that generated $2 billion across three live-action films is getting the cartoon treatment.

The directors? Zach Lipovsky and Adam B. Stein, who just made Final Destination: Bloodlines—a horror movie about elaborate death sequences.

That's an unusual pairing. Horror directors handling an animated superhero franchise is rare enough to raise questions about Sony's intentions. But the bigger question is whether Sony can replicate the Spider-Verse success with a character that thrives on body horror and violent anti-hero aesthetics.

Spider-Verse worked because of radical visual innovation and Miles Morales' deeply personal coming-of-age story. Venom's appeal is different—he eats people and has neurotic conversations with himself. Can that translate to animation aimed at broad audiences?

Sony's betting yes. Tom Hardy is involved in some capacity (producing or voicing, nobody's saying which yet). No writer is attached—they're assembling a writers' room to figure out the story. Release is probably 2029-2030 given animation timelines.

The studio clearly sees animation as a way to keep franchises alive between live-action installments. Disney does it with Marvel shows. Warner Bros. does it with DC animated films. Sony proved it works with Spider-Verse. Now they're testing whether the strategy extends to villain-led properties.

Why Animation Solves Live-Action Problems

Spider-Man: Into the Spider-Verse (2018) cost roughly $90 million and made $384 million worldwide. Across the Spider-Verse (2023) cost $100-150 million and made $690 million globally. Over $1 billion combined on budgets that are a fraction of typical superhero blockbusters.

Compare that to live-action Spider-Man films, which cost $200+ million and require coordinating actors, stunt teams, locations, and months of post-production.

For Venom specifically, animation addresses practical challenges:

Tom Hardy is a busy actor. Getting him for months of live-action filming is complicated. Voice recording for animation requires weeks, not months, and can happen on his schedule.

The Venom trilogy got bigger and more expensive with each film. The Last Dance (2024) had spectacle that pushed VFX costs high. Animation budgets are more predictable—you're not paying for on-set explosions or location shoots.

Animation handles body horror better than live-action. Venom's comic history includes alien planets, symbiote biology, and cosmic-level threats that would cost a fortune in CGI. Animation makes that visual language native instead of expensive.

The character stays viable indefinitely. Actors age, but animated characters don't. If Hardy doesn't want to voice Venom long-term, they can recast without audience backlash because it's already animated.

But here's what Sony isn't saying publicly: animation is also a hedge. If the film underperforms, it's a $100-150 million mistake instead of a $200+ million disaster. Lower financial risk means more creative freedom to experiment with tone and audience.

What Final Destination Directors Signal About Tone

Hiring Lipovsky and Stein matters. Final Destination: Bloodlines made $317 million worldwide on a $50 million budget—a solid horror hit that revived a dormant franchise.

Their filmography (Kim Possible, Freaks, Mech-X4) is uneven, but they understand how to execute genre work on mid-tier budgets. That's useful for a studio trying to prove animation can sustain a franchise without Marvel-level spending.

The horror connection is what makes this interesting. Venom isn't Spider-Man—he's a character defined by violence, body horror, and morally questionable choices. The live-action films straddled PG-13 boundaries, keeping things edgy without crossing into R-rated territory.

Animation could push darker. Castlevania on Netflix proved American audiences will watch violent, mature animated content. Japan's been doing it for decades. If Sony leans into the horror-action angle, an animated Venom film could be the first mainstream American superhero animation aimed specifically at adults.

That would differentiate it from Spider-Verse, which works for all ages. It would also match Venom's comic DNA—early Lethal Protector and Separation Anxiety stories weren't kid-friendly.

Whether Sony has the guts to make an R-rated animated superhero film is another question. Studios love hedging bets, and PG-13 ratings maximize ticket sales. But hiring horror directors at least suggests they're considering a darker tone.

The Tom Hardy Mystery

Tom Hardy hasn't just starred in the Venom trilogy—he shaped it. He developed Eddie Brock's neurotic, self-destructive personality. He improvised the romantic tension between Eddie and Venom that became the franchise's signature. He produced the later films.

His performance is Venom for an entire generation of fans. Recasting the voice would alienate the audience that just spent three movies bonding with Hardy's take on the character.

But voice acting requires time. If Hardy's film schedule is packed, he might not be available for recording sessions spread across years as animation develops.

Studios say Hardy is "involved in some capacity." That vagueness suggests negotiations are ongoing. Sony probably wants Hardy's voice for marketing purposes ("Tom Hardy returns as Venom!"). Whether Hardy wants to commit is the open question.

If he doesn't voice the character, Sony faces tough choices. Cast a soundalike and risk backlash? Reboot with a new Eddie Brock and start fresh? Focus on the symbiote's alien origins and avoid the Eddie Brock problem entirely?

Animation gives them flexibility to explore different takes on Venom. They could adapt Lethal Protector, Planet of the Symbiotes, or original stories. They could focus on other hosts from the comics. They could make this a prequel about Venom's time on other planets before reaching Earth.

But fans want Hardy. Social media reaction to the announcement immediately asked "Is Tom Hardy voicing him?" That's the question Sony needs to answer to build real hype.

What Story Could They Tell?

No writer means the story is wide open. Possibilities include:

Continuation of live-action trilogy - Picks up after The Last Dance (2024). Requires Hardy's voice to maintain continuity. Safest commercial choice.

Prequel exploring symbiote origins - Venom's time on other planets before bonding with Eddie Brock. Could work without Hardy if they focus on the alien side of Venom's mythology.

Alternate universe reboot - New take on Venom unconnected to live-action films. Risky because it confuses audiences who just watched three movies about this character.

Spider-Verse crossover setup - Introduces this Venom as part of Sony's animated multiverse, potentially crossing over with Miles Morales later. Ambitious but commercially smart—it links their two biggest animated properties.

The horror directors suggest a darker story. Maybe they adapt Lethal Protector (Venom as anti-hero protecting the innocent from worse threats) or Planet of the Symbiotes (cosmic horror about Venom's alien species invading Earth). Both would benefit from animation's visual freedom and work with a mature tone.

Sony's opening a writers' room rather than hiring one screenwriter. That suggests they want multiple pitches and approaches. Develop several takes, pick the strongest one, move forward. It's common for franchise films but adds development time.

Can This Work Without Spider-Man?

The Venom trilogy succeeded despite never showing Spider-Man (except multiverse teases). That's unusual—Venom's origin is tied to Spider-Man in the comics. Sony proved the character can work independently.

An animated Venom continues that strategy. They're building their own corner of the Marvel universe separate from Disney's MCU. Venom, Morbius, Kraven, Madame Web—Sony owns the film rights to Spider-Man and related characters through their licensing deal with Marvel.

Animation lets them experiment with lower financial risk. If animated Venom succeeds, maybe they make animated Kraven or animated Sinister Six. If it underperforms, they haven't blown the budget on a live-action tentpole.

The broader question is whether Venom has the depth to sustain multiple formats. Three live-action films plus an animated movie plus potential future installments—that's a lot of content for one character. Spider-Man can support it because he's had 60+ years of stories. Venom has 30+ years but less cultural penetration.

Sony's banking on the character's anti-hero appeal and Hardy's interpretation creating enough audience investment to keep people coming back. The live-action trilogy's $2 billion suggests that bet is sound. Whether it translates to animation depends on execution.

What Happens Next

Hollywood Reporter announced the deal but production details are scarce. Based on typical timelines:

Now (February 2026) - Writers' room assembles, multiple pitches developed, Sony picks direction

2026-2027 - Script development, casting (especially resolving Hardy's involvement), securing financing

2027-2028 - Production if greenlit. Animation requires extensive pre-production (design, storyboards, voice recording) and post-production (animation, VFX, sound)

2029-2030 - Earliest possible release if everything goes smoothly

That's optimistic. Development hell claims most projects. But Sony's track record with Spider-Verse (they actually finish projects) and the financial logic (lower risk than live-action) suggest this moves forward.

Key questions remain:

• Does Tom Hardy voice Venom or just produce?
• What story do they tell?
• How mature is the tone? PG-13 or R?
• Theatrical release or streaming?
• Do they connect it to Spider-Verse or keep it separate?

Answers will emerge over the next year as the project develops. For now, Sony's made a statement: animation isn't just for Spider-Man. They're testing whether it works for their entire Marvel catalog.

The Broader Strategy

Venom getting animated treatment validates Sony's approach. They discovered animation can be commercially successful and critically acclaimed with Spider-Verse. Now they're expanding the strategy to other properties.

This isn't charity—it's business. Studios need content. Streaming demands volume. Animation provides a way to keep franchises alive between major live-action releases without cannibalizing the mainline films.

Disney does this with Marvel Disney+ shows and animated series. Warner Bros. does it with DC animated movies that often outperform live-action counterparts in quality if not box office. Sony's learning from both.

If animated Venom succeeds, expect Sony to animate more of their Marvel catalog. Kraven, Morbius, Black Cat, Silver Sable—they have rights to dozens of Spider-Man-adjacent characters. Animation makes testing these characters commercially viable.

The risk is audience fatigue. How many Venom stories can one character sustain? How many formats can audiences track before they stop caring?

But Sony's betting that Venom—with Tom Hardy's performance or without it—has enough cultural weight to support expansion. Three live-action films grossing $2 billion is evidence. Whether animation replicates that success is the test.

The next two years will determine if Sony's Spider-Verse playbook is a formula or a fluke.

TAGGED: Venom, Sony Pictures Animation, Tom Hardy, Spider-Verse, Marvel, Animation, Final Destination